3rd Joint Transnational Call for Proposals (2020)

Basic Information

MULTIDISCIPLINARY RESEARCH PROJECTS ON PERSONALISED MEDICINE – PRE-/CLINICAL RESEARCH, BIG DATA AND ICT, IMPLEMENTATION AND USER’S PERSPECTIVE

Network

ERA PerMed

Website

http://www.erapermed.eu/joint-calls/joint-transnational-call-2020/

Aim of the joint call

The overall objectives of the call are to: - Support translational research projects in the field of Personalised Medicine; - Encourage and enable interdisciplinary collaborations towards the implementation of PM, combining pre-clinical and/or clinical research with bioinformatics components and research on relevant ethical, legal and social aspects and/or research on the optimisation of health care systems; - Encourage collaboration between academia (research teams from universities, higher education institutions, public research institutions), clinical/public health research (research teams from hospital/ public health, health care settings and other health care organisations), private partners e.g. SMEs (small and medium-sized enterprises) as well as policy makers, regulatory/HTA agencies and patient organisations.

Type of joint call

Two Stages - Call with pre-proposals and full proposals submissions

Events

-                                                Launch date
+/12/2019
-                                                Deadline Pre-Proposal
+/03/2020 Submitted proposal: 188
-                                                Deadline Full-Proposal
+/06/2020 Submitted proposal: 52
-                                                Evaluation End Date
+/10/2020
                                                Successful proposal: 0
                                                Proposals funded: 18

Is call co-funded?

Call follow up funding

There are mechanisms in place to monitor

Call reasons

Addressing specific scientific and technological issues

Research fields

Health

Type of research

Basic research
Applied Research
Pre-competitive research

Target groups

Public Research Organisations (PROs)
Private and Semi-private Research and Technology Organisations (RTOs)
SME (Small and Medium Enterprises)
Large Corporations

Participating networks

n/a

Organisations Participating

Show on map

Country	Organisation
Belgium	National Fund for Scientific Research (FNRS)
Canada	Quebec Research Fund - Health (FRQS)
Croatia	Ministry of Science, Education and Sports (MSES-MZOS)
Denmark	Innovation Fund Denmark (Innofond)
Egypt	Academy of Scientific Research and Technology (ASRT)
Finland	Academy of Finland (AKA)
France	National Research Agency (ANR)
Germany	Federal Ministry of Education and Research (BMBF)
Germany	Federal Ministry of Health (BMG)
Germany	German Aerospace Center (DLR)
Germany	Saxon State Ministry for science, culture and tourism (SMWK)
Germany	VDI/VDE Innovation + Technik GmbH (VDI/VDE-IT)
Greece	General Secretariat for Research and Technology (GSRT)
Hungary	National Research, Development and Innovation Office (NKFIH)
Ireland	Health Research Board (HRB)
Israel	Ministry of Health (CSO-MOH)
Italy	Lombardy Foundation for Biomedical Research (FRRB)
Italy	Ministry of Health (MOH/MDS)
Italy	Tuscany Region (TOS)
Latvia	State Education Development Agency (VIAA)
Luxembourg	National Fund for Research (FNR)
Norway	Research Council of Norway (RCN)
Panama	Secretariat of Science, Technology and Innovation (SENACYT)
Poland	National Centre for Research and Development (NCBiR)
Romania	Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI)
Slovenia	Ministry of Education, Science, Culture and Sport (MESCS/MIZS)
Spain	Centre for the Development of Industrial Technology (CDTI)
Spain	DEPARTMENT OF HEALTH - GOVERNMENT OF CATALONIA (DDS-GDC)
Spain	Government of Navarra (CFN)
Spain	Institute of Health Carlos III (ISCIII)
Spain	Spanish Association Against Cancer Scientific Foundation (AECC FC)
Sweden	Swedish Research Council (VR/SRC)
Turkey	The Scientific and Technological Research Council of Turkey (TUBITAK)

Funded Projects

Acronym	Title	No. partners
CLL-CLUE	Tailoring the targeted treatment of chronic lymphocytic leuk...	6
DECODE	Defining stratification of patients with C3 Glomerulopathies...	6
DIGIPD	Validating DIGItal biomarkers for better personalized treatm...	6
EV-glio	Plasma extracellular vesicles (EVs): the key for precision m...	6
HiRisk-HiGain	Rethinking personalized cancer therapy: targeting minimal r...	6
MSOP-PRE	Early PREdiction and personalized PREvention of Metabolic Sy...	5
ONCOLOGICS	Computational modelling and functional validation platform f...	6
OptiCAN	Optimized T cells for personalized immunotherapy for solid c...	4
PARIS	Precision drugs Against Resistance In Subpopulations	6
PMT-LC	Personalized multimodal therapies for the treatment of lung ...	5
PROGRESS	PRecisiOn medicine in CAD patients: artificial intelliGence ...	5
PROMPT	Toward PrecisiOn Medicine for the Prediction of Treatment re...	7
PerEpi	Personalised diagnosis and treatment for refractory focal pa...	4
PerMIDRIAR	Personalized medicine to tackle immune dysfunction in refrac...	5
PerPlanRT	Personalized planning in radiotherapy through integrative ...	6
Preserve	AI for new signatures and models for tailored organ preserva...	6
RESPECT	Renal MRI standardization to improve personalised management...	6
TIPS	Tailored Immunotherapy for Paediatric SIRS (severe inflammat...	5